- Increase the efficiency of prescription management.
- Improve patient adherence to medications.
- Detect and close gaps in care.
- Use advanced systems to personalize pharmacy care for patients with chronic conditions and complex therapeutic needs.
Mylan pushed the blame for high EpiPen prices onto PBMs Thursday, causing share prices to dip. Analysts say investors were mislead.
Express Scripts (ESRX) stock was rallying Friday afternoon following a bullish note at Jefferies.
Wall Street will look to comments from Fed Chair Janet Yellen on interest rates; futures are higher; Carl Icahn recently discussed selling his stake in Herbalife, a report says.
Leerink analysts say Express Scripts (ESRX) stock may be lower today as a result of Mylan's (MYL) continued EpiPen controversy.